WASHINGTON — The White House has decided to drop Heidi Overton from its pending nomination to lead the Food and Drug Administration (FDA). The decision comes after a period where administration officials had already been showing growing impatience regarding the progression of the nomination process.
Nomination Pulled
Reports from multiple major networks confirmed that the administration officially pulled the choice of Overton for the prominent health leadership role. Prior to the withdrawal, indications from Washington suggested that officials were growing increasingly anxious about the status of the nomination.
Developing Situation
Because the announcement is still quite fresh, further details surrounding the specific reasons for the withdrawal or the next steps for the FDA leadership vacancy remain limited. Observers note that additional information is expected to emerge as the story continues to develop.
Sources: CBS News, Seeking Alpha, NBC New York, ABC News
